D Boral ARC Acquisition I Corp (NASDAQ: BCAR) is a special purpose acquisition company (SPAC) incorporated in the British Virgin Islands that raised capital through an IPO to identify and complete a merger with a private operating business. The company generates no operating revenue. Its economic model depends entirely on deploying IPO proceeds held in trust toward a business combination, after which the SPAC shell ceases to exist as an independent entity. BCAR completed its IPO on August 1, 2025, selling 25,000,000 units at $10.00 per unit for gross proceeds of $250,000,000. Each unit included one Class A ordinary share and one-half of one redeemable warrant exercisable at $11.50 per share. On January 11, 2026, BCAR entered into a merger agreement with Exascale Labs Inc., a Delaware corporation, valuing the target at $500,000,000 through 50,000,000 newly issued shares at $10.00 per share. The sponsor, MFH 1, LLC, holds 28.57% of shares as of the 10-K filed March 16, 2026. The leadership team reports over 30 years of combined experience in private equity and investment banking, with involvement in more than 65 SPAC transactions exceeding $7 billion in combined transaction value since 2020.

Revenue model

No operating revenue. The SPAC structure holds IPO proceeds in trust and earns interest on those funds until a business combination closes. Economic return to the sponsor comes from founder shares (Class B ordinary shares) issued at nominal cost, which convert to Class A shares upon deal closing.

Products and services

IPO units consisting of Class A ordinary shares and redeemable warrants. 25,000,000 public units sold at $10.00 per unit (August 1, 2025). 200,000 private placement units sold to the sponsor at $10.00 per unit. Each whole warrant entitles the holder to purchase one Class A ordinary share at $11.50 per share.

Customers and end markets

Public equity investors are the capital providers. The intended end market is a private operating company seeking a public listing via SPAC merger. The announced merger target is Exascale Labs Inc., a Delaware corporation, with a $500,000,000 aggregate merger consideration as of January 11, 2026.

Value-chain role

SPAC sponsor and blank-check acquisition vehicle. Identifies, negotiates, and structures a merger with a private target to bring it public, acting as intermediary between private capital targets and public equity markets.

Geographic exposure

Incorporated in the British Virgin Islands. Principal office at 10 E. 53rd St. Suite 3001, New York, NY 10022. Merger target Exascale Labs Inc. is a Delaware corporation.

Source: SEC 10-K, filed 2026-03-16

Industry: Services-Prepackaged Software